Shuo Kang

565 total citations
22 papers, 369 citations indexed

About

Shuo Kang is a scholar working on Cellular and Molecular Neuroscience, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuo Kang has authored 22 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuo Kang's work include Neuroscience and Neuropharmacology Research (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Shuo Kang is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Shuo Kang collaborates with scholars based in China and United States. Shuo Kang's co-authors include Jing‐Gen Liu, Joshua M. Gulley, Guoqiang Liu, Zhi‐Qiang Chi, Charles L. Cox, Wentao Liu, Chuan Yu, Weisheng Wang, Jie Chen and Mu Li and has published in prestigious journals such as Journal of Neuroscience, Neuroscience and eLife.

In The Last Decade

Shuo Kang

21 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Kang China 12 204 101 79 71 48 22 369
Amanda Vernon United States 5 168 0.8× 160 1.6× 63 0.8× 59 0.8× 22 0.5× 5 390
Kerry A. Waters United Kingdom 6 175 0.9× 146 1.4× 88 1.1× 69 1.0× 56 1.2× 6 347
Omkar L. Patkar Australia 13 163 0.8× 141 1.4× 54 0.7× 23 0.3× 16 0.3× 27 448
Zhiguang Lin China 13 74 0.4× 102 1.0× 59 0.7× 29 0.4× 16 0.3× 30 494
Elisa Neri Italy 9 176 0.9× 147 1.5× 26 0.3× 39 0.5× 18 0.4× 18 337
Yuntao Ma China 7 181 0.9× 143 1.4× 28 0.4× 20 0.3× 36 0.8× 16 340
Vincent Law United States 7 81 0.4× 105 1.0× 75 0.9× 65 0.9× 63 1.3× 21 401
Melissa Banks United Kingdom 9 176 0.9× 119 1.2× 42 0.5× 103 1.5× 12 0.3× 17 424
Catherine Curran United States 10 153 0.8× 148 1.5× 69 0.9× 97 1.4× 48 1.0× 34 582
Po‐Wu Gean Taiwan 11 292 1.4× 189 1.9× 78 1.0× 19 0.3× 13 0.3× 24 475

Countries citing papers authored by Shuo Kang

Since Specialization
Citations

This map shows the geographic impact of Shuo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Kang more than expected).

Fields of papers citing papers by Shuo Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Kang. The network helps show where Shuo Kang may publish in the future.

Co-authorship network of co-authors of Shuo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Kang. A scholar is included among the top collaborators of Shuo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Kang. Shuo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wenjie, et al.. (2023). Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis. Frontiers in Pharmacology. 14. 1131219–1131219. 1 indexed citations
3.
Zhang, Boyuan, et al.. (2023). Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China. Expert Review of Pharmacoeconomics & Outcomes Research. 23(3). 337–343. 3 indexed citations
4.
Kang, Shuo, Xiaohui Wang, Zhenhua Pan, & Huanlong Liu. (2023). Cost-effectiveness analysis of toripalimab plus chemotherapy for patients with advanced esophageal squamous cell carcinoma in China. Expert Review of Pharmacoeconomics & Outcomes Research. 24(2). 285–292. 1 indexed citations
5.
6.
7.
Xenias, Harry S., Chuyu Chen, Shuo Kang, et al.. (2022). R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations. Communications Biology. 5(1). 1211–1211. 9 indexed citations
8.
Kang, Shuo & Xuan Zhang. (2022). [Research Progress in Mechanism of Lipid Nephrotoxicity].. PubMed. 44(5). 914–918. 1 indexed citations
9.
10.
Liu, Guoqiang & Shuo Kang. (2021). Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China. Expert Review of Pharmacoeconomics & Outcomes Research. 22(1). 85–91. 16 indexed citations
11.
Yang, Junhua, et al.. (2018). Effects of mindfulness training on diabetes-related distress and quality of life in patients with type 2 diabetes mellitus. Zhonghua xiandai huli zazhi. 24(2). 186–189. 2 indexed citations
12.
13.
Wang, Weisheng, Qi‐Xin Zhou, Jianxin Tang, et al.. (2017). The Small GTPase Rac1 Contributes to Extinction of Aversive Memories of Drug Withdrawal by Facilitating GABAA Receptor Endocytosis in the vmPFC. Journal of Neuroscience. 37(30). 7096–7110. 19 indexed citations
14.
15.
16.
Kang, Shuo, et al.. (2015). Application of telephone follow-up on the initial use of insulin glargine in patients with extended care. Zhonghua xiandai huli zazhi. 21(36). 4385–4387. 1 indexed citations
17.
Kang, Shuo, Wentao Liu, Bin Lu, et al.. (2013). Down-regulation of dorsal striatal RhoA activity and impairment of working memory in middle-aged rats. Neurobiology of Learning and Memory. 103. 3–10. 14 indexed citations
18.
19.
Lü, Gang, Qi‐Xin Zhou, Shuo Kang, et al.. (2010). Chronic Morphine Treatment Impaired Hippocampal Long-Term Potentiation and Spatial Memory via Accumulation of Extracellular Adenosine Acting on Adenosine A1Receptors. Journal of Neuroscience. 30(14). 5058–5070. 74 indexed citations
20.
Hou, Yuanyuan, Yao Liu, Shuo Kang, et al.. (2009). Glutamate receptors in the dorsal hippocampus mediate the acquisition, but not the expression, of conditioned place aversion induced by acute morphine withdrawal in rats. Acta Pharmacologica Sinica. 30(10). 1385–1391. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Vernon Breakdown of academic impact, for papers by Kerry A. Waters Breakdown of academic impact, for papers by Omkar L. Patkar Breakdown of academic impact, for papers by Zhiguang Lin Breakdown of academic impact, for papers by Elisa Neri Breakdown of academic impact, for papers by Yuntao Ma Breakdown of academic impact, for papers by Vincent Law Breakdown of academic impact, for papers by Melissa Banks Breakdown of academic impact, for papers by Catherine Curran Breakdown of academic impact, for papers by Po‐Wu Gean
Rankless by CCL
2026